In this review, we summarize the recent progress of the role of PTL and analogues in various conditions with emphasis on osteolytic diseases, primary and metastasis bone cancers, and COVID-19, which helps to fill the gap of knowledge through our investigation and discussion of the role of PTL and its derivatives in skeletal disease and cytokine storm. The gene discussed is PNLIP; the disease is bone cancer.